New and Emerging Topical Treatments for AKs

Actinic keratoses are the second most common reason patients visit the dermatologist. In the second podcast of this educational program, Dr. Todd Schlesinger discusses new and emerging topical treatments for AKs, including photodynamic therapies, topical agents, and more.  About the Series This 3-part educational podcast series provides a detailed examination of the disease state and […]

Tips for Treating Rosacea and Acne

Dr. Hilary Baldwin offers several tips for optimally treating acne and rosacea for new and experienced providers, alike.  Hilary Baldwin, MD, Medical Director, Acne Treatment and Research Center, Brooklyn, New York Rosacea: Tip 1 “Let’s start with rosacea, since we always start with acne. If I had one tip to give on rosacea, regardless of […]

Core Values for Practice Growth   

Dr. Robyn Siperstein discusses practice growth strategies based on core values, including “caring” and more for patients and staff. Robyn Siperstein, MD, Siperstein Dermatology Group, Boca Raton and Boynton Beach, Florida  “I grew all my office policies around my core values, which is how I was able to grow a practice that I started with […]

Peel Regimens in Skin of Color 

Dr. Jaishree Sharad shares tried and true peel regimens from 23 years of practice with skin of color patients in Mumbai, India. Jaishree Sharad, MD, Cosmetic Dermatologist, Skinfinitii Aesthetic Skin and Laser Clinic, Mumbai, India “The first thing we need to know about doing peels in skin of color is we always restrict ourselves to […]

The Latest on Treating Pigmentation with Lasers

Dr. Roy G. Geronemus discusses how laser technology has evolved to safely and effectively treat common pigmentary concerns.  Roy D. Geronemus, MD, Director, Laser & Skin Surgery Center of New York in New York City and Clinical Professor of Dermatology, New York University Medical Center “The topic that I presented at the recent ASDS meeting was on using […]

Literature Lessons – December

Including the latest on acne, psoriasis, atopic dermatitis, hair and nails, hidradenitis suppurativa, rheumatologic diseases, and more. GENERAL DERMATOLOGY Using data derived from a global health records database, the investigators compared the relative risk of developing hematologic malignancy among 327,502 patients with UNCLASSIFIED GENERALIZED PRURITUS compared to a similarly sized matched cohort of patients without […]

Off-Label Pearl

Dr. Ted Rosen reviews a case study suggesting dermal microinjections of botulinum toxin A (BTX-A) can improve facial flushing and erythema in patients with refractory rosacea. Botulinum Toxin Microdroplets for Refractory Rosacea Erythema By Ted Rosen, MD, FAADEditor-in-Chief  What would you do if a rosacea patient had persistent severe facial erythema and telangiectasia despite the […]

Literature Update: Screening for Syphilis

Dr. Ted Rosen discusses a newly published US Preventive Services Task Force reaffirmation recommendation statement that says with high certainty that there is significant net benefit to syphilis screening for nonpregnant people who are at increased infection risk.  USPSTF Makes “A” Recommendation to Screen for Syphilis By Ted Rosen, MD, FAADEditor-in-Chief Syphilis, which is characterized […]

New Drugs: Deucravacitinib for Plaque Psoriasis

Dr. Ted Rosen reports on the FDA’s recent approval of deucravacitinib, the first drug in its class for treatment of moderate to severe plaque psoriasis in patients who are candidates for systemic therapy and phototherapy.  Ted Rosen, MD, FAAD  Editor-in-Chief As the first drug in its class, deucravacitinib (Sotyktu, Bristol Myers Squibb) has received FDA […]

New Drugs: Dupilumab for Prurigo Nodularis

Dr. Ted Rosen discusses the FDA’s recent approval of dupilumab as the first FDA-approved treatment for adults with prurigo nodularis. By Ted Rosen, MD, FAADEditor-in-Chief Based upon the results of two phase 3 trials (PRIME, PRIME 2), the FDA has approved dupilumab (Dupixent, Sanofi Regeneron) for the treatment of prurigo nodularis in adults. Dupilumab is, […]